A new book by Nathaniel Chin, MD, "When Memory Fades: What to Expect at Every Stage, from Early Signs to Full Support for Alzheimer’s and Dementia," offers a clear and compassionate guide for people navigating Alzheimer’s disease and related dementias.
Welcome
The Wisconsin Alzheimer’s Disease Research Center supports researchers in their pursuit of answers that will lead to improved diagnosis and care for patients while, at the same time, focusing on the program’s long-term goal — finding a way to prevent and effectively treat Alzheimer’s disease.
Recent News
Image
Sterling Johnson, PhD, has been named to Clarivate’s Highly Cited Researchers 2025 list. This honor recognizes researchers whose work has significant and far-reaching influence. Highly Cited Researchers represent just 1 in 1,000 scientists and social scientists worldwide.
Image
Nearly three hundred people attended the 2026 Alzheimer’s Disease & Related Dementias Research Day on April 15 in person and online. Research Day was started in 2014 to encourage collaboration and promote scientific thought among faculty, students and researchers from a wide range of disciplines across the UW–Madison campus.
Image
Nathaniel Chin, MD, will present a keynote talk, and several experts from the University of Wisconsin School of Medicine and Public Health will lead workshops at this year's Alzheimer’s Association Wisconsin State Conference.
Image
Sterling Johnson, PhD, is co-author of a Policy View in the March issue of The Lancet Neurology. The paper offers recommendations in Alzheimer’s disease treatment and prevention, with important considerations for treatments in people who are cognitively unimpaired but at risk of future symptoms.
Image
The Wisconsin Alzheimer’s Disease Research Center (ADRC) is now accepting Letters of Intent (LOI) for the Developmental Project Award to support a feasibility study targeting Alzheimer’s disease and related dementias (ADRD) research. The Letter of Intent (LOI) deadline is at 11:59 p.m. CT on February 27, 2026.
